Toronto family’s battle highlights challenges of diagnosing and treating PANS in children

A Toronto family’s ordeal with their daughter’s sudden and severe neuropsychiatric symptoms sheds light on the complexities of diagnosing and treating paediatric acute-onset neuropsychiatric syndrome, amid ongoing debates and limited consensus within the medical community.

What began as a routine sore throat in September 2025 turned into a medical crisis that changed one Toronto family’s understanding of childhood illness, psychiatry and the limits of the health system. Within days, Rose, 8, moved from mild flu-like symptoms to violent involuntary movements, desperate agitation and a terrifying change in behaviour that left her parents fearing for her safety and their own.

At first, doctors suggested a virus might be producing unusual symptoms. That explanation quickly gave way to something far more alarming: Rose began saying she wanted to hurt her parents, ripped off her clothes and spent hours screaming, kicking and biting. Her mother, who works in social work and knows the language of psychiatric diagnosis, realised that her daughter’s sudden collapse did not fit the pattern of a standard mental-health disorder. Yet the family was repeatedly told to treat it as one.

The turning point came when her mother recognised the cluster of symptoms as possible PANS, short for paediatric acute-onset neuropsychiatric syndrome, a condition that NIMH describes as sudden-onset OCD or restrictive eating paired with a range of other neuropsychiatric and physical symptoms. The federal institute says treatment can include psychiatric medication, antibiotics, anti-inflammatory drugs and immune-based therapies, although the condition remains uncommon and under active study. A 2012 NIMH update broadened the earlier PANDAS concept beyond strep throat alone, and a 2017 NIMH guidance page set out a multidisciplinary treatment approach.

For many families, the hardest part is not recognising the illness but finding a clinician willing to treat it. That problem has long shadowed PANS and PANDAS, even as researchers at places such as Stanford, Columbia, Yale and Harvard have increasingly explored inflammatory and immune pathways. A 2015 review co-authored by Susan Swedo described antibiotics, anti-inflammatory drugs, immune-modulating therapies and behavioural treatment as part of a broad care plan, while later research has continued to look for biological markers and evidence of neuroinflammation.

In Rose’s case, a short course of azithromycin and ibuprofen seemed to bring the first real change. She still needed care and remained highly distressed, but she stopped assaulting her parents and slept through the night for the first time in a week. When a specialist later recommended a longer course of antibiotics, naproxen and possibly IVIG, the family entered the expensive and emotionally draining world many PANS parents describe: travelling for expertise, seeking second opinions and trying to overcome a medical culture that often treats the diagnosis with suspicion.

That tension remains central to the condition’s story. In 2024, the American Academy of Pediatrics said PANS is “likely valid”, but it recommended conservative treatment centred on the therapies used for OCD and Tourette’s syndrome while urging more research. Advocates see that stance as too narrow, especially when families are fighting insurers that cite such guidance to deny coverage for IVIG and related care. According to NIMH materials and published reviews, the syndrome is still being defined, and there is no single reliable diagnostic test.

The family ultimately paid out of pocket for IVIG in Buffalo before securing monthly treatment closer to home. The results were gradual but unmistakable: Rose started asking for clothes, books, music and new foods. More recently, she reached out for a hug for the first time in months. Her progress does not resolve the broader debate around PANS, but it underscores what is at stake when a disputed diagnosis meets a child in acute distress: years of uncertainty, the risk of permanent harm and the possibility that a difficult-to-recognise inflammatory illness is being mistaken for something else.

Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.